PYC pyc therapeutics limited

pathway to a collaboration, page-3

  1. 6,308 Posts.
    lightbulb Created with Sketch. 22450
    With respect to the Soucek et al abstract to be presented on 20 April at the American Council of Cancer Research’s Annual Meeting , from the abstract body

    Here we discuss our current research with Omomyc and our efforts to develop a clinically viable approach to Myc inhibition.

    One is based on the direct use of Omomyc itself as a peptide since we have discovered that it natively possesses cell-penetrating activity and it rapidly biodistributes to the lung and brain after intranasal administration.

    What does “natively possesses” mean in this context?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.30
Change
0.030(2.36%)
Mkt cap ! $752.4M
Open High Low Value Volume
$1.27 $1.31 $1.27 $213.8K 165.4K

Buyers (Bids)

No. Vol. Price($)
2 1301 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.30 772 1
View Market Depth
Last trade - 15.29pm 30/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.